Starpharma Holdings Limited

ÜBERBLICK |  NEWS |  MULTIMEDIA  | FORSCHUNG

---

Starpharma Holdings Limited Company Summary

Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a world leader in the development of dendrimer nanotechnology for pharmaceutical, life-science and other applications. SPL is principally composed of two operating companies, Starpharma Pty Ltd in Melbourne, Australia and Dendritic Nanotechnologies, Inc in Michigan, USA. Products based on SPL's dendrimer technology are already on the market in the form of diagnostic elements and laboratory reagents. The Company's lead pharmaceutical development product is VivaGel(R) (SPL7013 Gel), a vaginal microbicide designed to prevent the transmission of STIs, including HIV and genital herpes.

ANNUAL REPORT

COMPANY DATA

	Headquarters	Baker Building
		75 Commercial Road
		Melbourne VIC 3004
		AUSTRALIA
	Telephone	+61 3 8532 2700
	Fax	+61 3 9510 5955
	Principal Sector	Gesundheit & Pharm
	Principal Industry	Biotechnology
	Listed	2000/09/28
	Homepage	www.starpharma.com

14,373 COMPANY PROFILE VIEWS

Diese Seite wurde besucht: (letzten 7 Tagen: 27) (letzten 30 Tagen: 119) (seit Veröffentlichung: 2247)